[Skip to Content]
[Skip to Content Landing]
June 17, 1988

Vasodilator Therapy for Heart Failure: What Have We Learned From Controlled Clinical Trials?

Author Affiliations

University of Minnesota Medical School Minneapolis

University of Minnesota Medical School Minneapolis

JAMA. 1988;259(23):3456-3457. doi:10.1001/jama.1988.03720230066034

Vasodilator therapy has now gained wide acceptance as appropriate adjuvant drug treatment for congestive heart failure. Although this therapy previously was reserved for relief of persistent symptoms in patients who were already taking digitalis and diuretics, recent data have provided support for the concept that use of these drugs may prolong life in addition to relieving symptoms.1,2 The evidence that systemic